☆ 4.7 Letter

B-cell chronic lymphocytic leukaemia presenting as lower motor neuron disease and SS

RHEUMATOLOGY (2012)

Journal

RHEUMATOLOGY

Volume 51, Issue 7, Pages 1338-1340

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/rheumatology/kes017

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Hematology

The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemia

Chaitra Ujjani, Mazyar Shadman, Ryan C. Lynch, Brian Tu, Philip A. Stevenson, Caitlin Grainger, Haiying Zhu, Joshua A. Hill, Meei-Li Huang, Leslie Nielsen, Christina Poh, Tyler Sorensen, Ajay K. Gopal, Edus H. Warren, Brian G. Till, Sydney Lee, Daria Gausman, Stephen D. Smith, Ted Gooley, Alex Greninger

Summary: This study found that SARS-CoV-2 vaccine efficacy was lower in chronic lymphocytic leukemia (CLL) patients, with decreased rates of seroconversion and lower antibody levels compared to healthy controls. The results from the Roche anti-S assay and neutralization activity were similar. Durable immune responses were observed up to six months, and booster shots were effective in improving the immune response in patients who had a response. The absence of normal B cells, commonly seen in CLL patients receiving certain treatments, was a strong predictor of lack of seroconversion.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Hematology

Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness

Filippo Severin, Nayla Mouawad, Edoardo Ruggeri, Andrea Visentin, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Stefano Pravato, Francesco Angotzi, Monica Facco, Livio Trentin, Federica Frezzato

Summary: Signalling events downstream the B-cell receptor (BCR) are crucial for survival and progression of chronic lymphocytic leukemia (CLL) cells. Focal adhesion kinase (FAK), regulated by calpain, interacts with molecules involved in BCR signalling and disease progression, such as Src/Lyn, cortactin, and HS1. The down-modulation of FAK and its cleavage due to calpain activity were observed upon BCR stimulation. Additionally, FAK inhibitor treatment induced apoptosis in CLL cells, suggesting a potential druggable pathway involving FAK, cortactin, and HS1 in CLL pathogenesis.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Article Genetics & Heredity

Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia

Qiuyi Zhang, Ying Gao, Shuchun Lin, Lynn R. Goldin, Yonghong Wang, Holly Stevenson, Daniel C. Edelman, Keith Killian, Gerald Marti, Paul S. Meltzer, Song Xiang, Neil E. Caporaso

Summary: This study investigated the DNA methylation aberrations in malignant B lymphocytes of CLL patients and identified differentially methylated positions (DMPs) and differentially methylated and expressed genes (DMEGs) associated with CLL by integrating public databases. The direction of each DMEG in CLL was observed based on DMPs in the promoter and the body region, and the methylation heterogeneity of CLL subgroups and the effect of B cell maturation on CLL were explored. The findings suggest the importance of DNA methylation in the pathogenesis of CLL and provide potential markers for diagnostic and therapeutic purposes.

FRONTIERS IN GENETICS (2023)

Add to Collection

Article Hematology

T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation

John F. Imbery, Julia Heinzelbecker, Jenny K. Jebsen, Marc McGowan, Camilla Myklebust, Nunzio Bottini, Stephanie M. Stanford, Sigrid S. Skanland, Anders Tveita, Geir E. Tjonnfjord, Ludvig A. Munthe, Peter Szodoray, Britt Nakken

Summary: Chronic lymphocytic leukaemia (CLL) is a malignancy characterized by mature B cells. Emerging evidence shows that CLL cells proliferate in response to T-helper (Th) cells in a CD40L-dependent manner. The study demonstrates that Th cells upregulate CD45 activity in CLL cells, leading to enhanced downstream antigen receptor signaling and proliferation. The increased expression of Galectin-1 and CD43, both of which are involved in CD45 regulation, was also observed. Targeting Galectin-1 or CD43 could dampen CD45 activity and CLL cell proliferation. These findings suggest that modulation of CD45 phosphatase activity could be a potential therapeutic target in CLL.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Hematology

Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells

Chiara Cavallini, Marilisa Galasso, Elisa Dalla Pozza, Roberto Chignola, Ornella Lovato, Ilaria Dando, Maria G. Romanelli, Mauro Krampera, Giovanni Pizzolo, Massimo Donadelli, Maria T. Scupoli

Summary: The study revealed the negative regulatory effects of CD20 monoclonal antibodies and their combination with BAKi on BCR signaling and cell survival in CLL. Additionally, the combination of CD20 mAbs and BAKi significantly enhanced leukemia cell death, indicating the potential of combined therapies in CLL patients.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia

Veronika Ecker, Martina Stumpf, Lisa Brandmeier, Tanja Neumayer, Lisa Pfeuffer, Thomas Engleitner, Ingo Ringshausen, Nina Nelson, Manfred Juecker, Stefan Wanninger, Thorsten Zenz, Clemens Wendtner, Katrin Manske, Katja Steiger, Roland Rad, Markus Mueschen, Juergen Ruland, Maike Buchner

Summary: Current therapeutic approaches in CLL focus on suppressing the PI3K/AKT signaling pathway, but research shows that CLL cells are vulnerable to hyperactivation of this pathway, which may be a promising concept for CLL therapy.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Oncology

Ethnic and geographic diversity of chronic lymphocytic leukaemia

Shenmiao Yang, Abraham M. Varghese, Nitin Sood, Carlos Chiattone, Norah O. Akinola, Xiaojun Huang, Robert Peter Gale

Summary: East Asians, Asian Indians, and Amerindians have a significantly lower incidence rate of chronic lymphocytic leukemia compared to persons of European descent, suggesting a genetic rather than environmental basis for this disparity. These populations have different genetic admixtures with archaic hominins, potentially explaining the varying CLL incidences among them, as well as differences in clinical and molecular covariates of CLL. Further research is needed to determine the exact reasons behind these population variances in CLL and other lymphomas and cancers.

LEUKEMIA (2021)

Add to Collection

Article Clinical Neurology

GGC repeat expansions in NOTCH2NLC causing a phenotype of lower motor neuron syndrome

Wei Zhang, Jing Ma, Jiaying Shi, Shan Huang, Rongjuan Zhao, Xiaomin Pang, Juan Wang, Junhong Guo, Xueli Chang

Summary: The GGC repeat expansion in the 5' untranslated region of NOTCH2NLC gene is associated with a new phenotype of hereditary lower motor neuron syndrome. NOTCH2NLC genotyping should be performed to aid in the diagnosis of hereditary lower motor neuron syndromes.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Will New Drugs Replace Transplants for Chronic Lymphocytic Leukaemia?

Shenmiao Yang, Xiaojun Huang, Robert Peter Gale

Summary: Transplantation has been used to treat chronic lymphocytic leukemia for over 35 years, but is only considered for less than 1% of highly selected patients. While some patients may achieve long-term leukemia-free survival with transplants, they also come with significant morbidity and mortality. The anti-leukemia effects of transplants are influenced by various factors, including drugs, radiation, and immune mechanisms.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Hematology

Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma

Shazia Nakhoda, Aldana Vistarop, Y. Lynn Wang

Summary: Bruton tyrosine kinase inhibitors (BTKi) have had a significant impact on the treatment of chronic lymphocytic leukaemia (CLL) and non-Hodgkin lymphoma. However, resistance to BTKi remains a challenge, and this review article provides an update on the key clinical data, mechanisms of resistance, and ongoing clinical investigations in CLL, mantle cell lymphoma, and diffuse large B-cell lymphoma (DLBCL).

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells

Gina L. Eagle, John M. J. Herbert, Jianguo Zhuang, Melanie Oates, Umair T. Khan, Neil R. Kitteringham, Kim Clarke, B. Kevin Park, Andrew R. Pettitt, Rosalind E. Jenkins, Francesco Falciani

Summary: This study utilized SWATH-MS technology for quantitative proteomic analysis of CLL, revealing significant overlap in functional enrichment analysis of proteins associated with IGHV mutational status with previous gene expression profiling studies. Additionally, statistical power analysis methods were implemented in the study.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Multidisciplinary Sciences

Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks

Zuzana Mikulkova, Gayane Manukyan, Peter Turcsanyi, Milos Kudelka, Renata Urbanova, Jakub Savara, Eliska Ochodkova, Yvona Brychtova, Jan Molinsky, Martin Simkovic, David Starostka, Jan Novak, Ondrej Janca, Martin Dihel, Pavlina Ryznerova, Lekaa Mohammad, Tomas Papajik, Eva Kriegova

Summary: The tissue microenvironment in CLL plays a key role in the pathogenesis of this disease, with high inter-individual heterogeneity observed in the distribution and activation of immune cells depending on the bulk of CLL cells. High CLL counts were associated with low activation on circulating monocytes and T cells, while the highest activation of immune cells was seen in patients treated with novel agents.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Oncology

Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling

Evan A. Mulligan, Susan J. Tudhope, Jill E. Hunter, Arabella E. G. Clift, Sarah L. Elliott, Geoffrey P. Summerfield, Jonathan Wallis, Chris J. Pepper, Barabara Durkacz, Stephany Veuger, Elaine Willmore

Summary: This study demonstrates the importance of RelB in CLL, as high basal levels of RelB DNA binding correlate with nuclear RelB protein expression and are associated with poor clinical outcomes. CD40L stimulation promotes RelB activation and CLL cell proliferation. Inhibiting non-canonical NF-kappa B signalling may be a novel therapeutic approach for CLL.

CANCERS (2023)

Add to Collection

Article Oncology

Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia

Carmela Ciardullo, Katarzyna Szoltysek, Peixun Zhou, Monika Pietrowska, Lukasz Marczak, Elaine Willmore, Amir Enshaei, Anna Walaszczyk, Jia Yee Ho, Vikki Rand, Scott Marshall, Andrew G. Hall, Christine J. Harrison, Meera Soundararajan, Jeyanthy Eswaran

Summary: This study investigates the clinical significance of B-cell regulators BACH2 and BCL6 in chronic lymphocytic leukaemia (CLL). The results show that low levels of BACH2 and BCL6 RNA expression are associated with shorter overall survival in CLL patients.

CANCERS (2022)

Add to Collection

Article Oncology

Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia

Helen Parry, Graham McIlroy, Rachel Bruton, Sarah Damery, Grace Tyson, Nicola Logan, Chris Davis, Brian Willett, Jianmin Zuo, Myah Ali, Manjit Kaur, Christine Stephens, Dawn Brant, Ashley Otter, Tina McSkeane, Hayley Rolfe, Sian Faustini, Alex Richter, Sophie Lee, Farooq Wandroo, Salim Shafeek, Guy Pratt, Shankara Paneesha, Paul Moss

Summary: Patients with chronic lymphocytic leukaemia (CLL) show impaired antibody responses following dual COVID-19 vaccination and a reduced ability to neutralize the globally dominant Delta variant. Male gender, BTKi therapy, prophylactic antibiotics use, and low serum IgA/IgM are risk factors for poor response.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Add to Collection

Article Immunology

A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness

Costas A. Constantinou, Dimitrios C. Ziogas, Aliki Venetsanopoulou, Maria N. Gamaletsou, Loukia Koutsogeorgopoulou, Anastasia Barbouni, Athanasios G. Tzioufas, Nikolaos Sipsas

Summary: The pneumococcal vaccination rate among patients with autoimmune rheumatic diseases in Greece is suboptimal, with only 49.37% receiving the vaccine. Factors influencing vaccine uptake include patient age and awareness of the reasons for vaccination, while lack of recommendation by physicians is the main reason for non-vaccination.

VACCINE (2021)

Add to Collection

Article Medicine, General & Internal

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome

Evangelia Argyriou, Adrianos Nezos, Petros Roussos, Aliki Venetsanopoulou, Michael Voulgarelis, Kyriaki Boki, Athanasios G. Tzioufas, Haralampos M. Moutsopoulos, Clio P. Mavragani

Summary: The study revealed a significant increase in the prevalence of the functional LILRA3 gene variant in SS patients with an onset of <40 years old, suggesting a higher risk for SS-related lymphoma development in this population.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Letter Rheumatology

Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'

Aimilios Kaklamanos, Panagiotis Karamichalos, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas

ANNALS OF THE RHEUMATIC DISEASES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology

Ioanna E. Stergiou, Konstantinos Kambas, Aikaterini Poulaki, Stavroula Giannouli, Theodora Katsila, Aglaia Dimitrakopoulou, Veroniki Vidali, Vasileios Mouchtouris, Ismini Kloukina, Evangelia Xingi, Stamatis N. Pagakis, Lesley Probert, George P. Patrinos, Konstantinos Ritis, Athanasios G. Tzioufas, Michael Voulgarelis

Summary: Myelodysplastic syndromes (MDS) involve a group of disorders affecting hematopoietic stem and progenitor cells, with a particular focus on the role of the transcription factor HIF-1. Aberrant HIF-1 stabilization and pseudohypoxia are prominent features in MDS pathobiology, showing potential for therapeutic manipulation in benign cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Rheumatology

Neutrophil extracellular traps in giant cell arteritis biopsies: presentation, localization and co-expression with inflammatory cytokines

Dimitris Anastasios Palamidas, Ourania D. Argyropoulou, Natalia Georgantzoglou, Elli Karatza, Evangelia Xingi, Efstathia K. Kapsogeorgou, Constantinos D. Anagnostopoulos, Andreas C. Lazaris, Konstantinos Ritis, Andreas Goules, Konstantinos Kambas, Athanasios G. Tzioufas

Summary: This study explores the presence of neutrophil extracellular traps (NETs) in inflamed temporal artery biopsies (TABs) of patients with GCA. The results demonstrate the presence of NETs and NETs bearing pro-inflammatory cytokines in TABs of GCA patients.

RHEUMATOLOGY (2022)

Add to Collection

Article Immunology

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjogren's Syndrome-Related Lymphoma?

Adrianos Nezos, Charalampos Skarlis, Anna Psarrou, Konstantinos Markakis, Panagiotis Garantziotis, Asimina Papanikolaou, Fotini Gravani, Michael Voulgarelis, Athanasios G. Tzioufas, Michael Koutsilieris, Haralampos M. Moutsopoulos, Eleni Kotsifaki, Clio P. Mavragani

Summary: The study aimed to investigate the contributory role of Lp-PLA2 in B-NHL development in primary SS patients. Results showed that serum Lp-PLA2 activity was significantly increased in SS-L patients, and Lp-PLA2 expression in MSG tissues was also higher in SS-L patients compared to SS-nL patients and healthy controls. These findings suggest that Lp-PLA2 could potentially serve as a new biomarker and therapeutic target for B-cell lymphoproliferation in the context of SS.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

Aimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, Vassilis G. G. Gorgoulis, Panayiotis G. G. Vlachoyiannopoulos, Athanasios G. G. Tzioufas

Summary: COVID-19 pathophysiology is largely influenced by immune deregulation, resulting in various severe consequences such as immune system malfunction, endothelial activation and inflammation, as well as immunothrombosis. These insights could potentially offer new opportunities in disease prevention and treatment.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjogren's Syndrome

Loukas Chatzis, Andreas Goules, Ioanna E. Stergiou, Michael Voulgarelis, Athanasios G. Tzioufas, Efstathia K. Kapsogeorgou

Summary: Recent studies have shown that elevated CXCL13 serum levels are associated with histologic features, disease severity and NHL risk in pSS patients, while saliva levels have limited discriminative value. Serum CXCL13 levels are positively correlated with CXCL13+-cell number and biopsy focus-score, indicating a potential role in disease severity and NHL development.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

Patient-centered approaches for patients with systemic autoimmune rheumatic diseases: development and evolution

Panayiotis G. Vlachoyiannopoulos, Loukas G. Chatzis, Andreas Goules, Ourania D. Argyropoulou, Adamantia Englezopoulou, Ioanna Stergiou, Michalis Voulgarelis, Panayiotis Tsanakas, Themis Exarchos, Vassilis V. Gorgoulis, Dimitrios Fotiadis, Athanasios G. Tzioufas

Summary: This article presents a literature review on the basic characteristics of a center of excellence dedicated to SARDs, its advantages over existing health infrastructures, its contribution to healthcare worker education, and the research opportunities it provides. The authors also share their experience, vision, and initiatives as a new member of the ERNs.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Addressing the clinical unmet needs in primary Sjogren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts

Vasileios C. Pezoulas, Andreas Goules, Fanis Kalatzis, Luke Chatzis, Konstantina D. Kourou, Aliki Venetsanopoulou, Themis P. Exarchos, Saviana Gandolfo, Konstantinos Votis, Evi Zampeli, Jan Burmeister, Thorsten May, Manuel Marcelino Perez, Iryna Lishchuk, Thymios Chondrogiannis, Vassiliki Andronikou, Theodora Varvarigou, Nenad Filipovic, Manolis Tsiknakis, Chiara Baldini, Michele Bombardieri, Hendrika Bootsma, Simon J. Bowman, Muhammad Shahnawaz Soyfoo, Dorian Parisis, Christine Delporte, Valerie Devauchelle-Pensec, Jacques-Olivier Pers, Thomas Doerner, Elena Bartoloni, Roberto Gerli, Roberto Giacomelli, Roland Jonsson, Wan-Fai Ng, Roberta Priori, Manuel Ramos-Casals, Kathy Sivils, Fotini Skopouli, Witte Torsten, Joel A. G. van Roon, Mariette Xavier, Salvatore De Vita, Athanasios G. Tzioufas, Dimitrios Fotiadis

Summary: This article presents the HarmonicSS cloud computing exemplar platform, which provides state-of-the-art data analytics services to address the clinical unmet needs of primary Sjogren's Syndrome (pSS). The platform successfully develops lymphoma classification models and identifies biomarkers for lymphomagenesis by interlinking, curating, and harmonizing multiple regional and international databases. The federated AI algorithms trained on the harmonized databases yield robust lymphoma classification models with high accuracy and identify 5 biomarkers for lymphoma development.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Add to Collection

Article Endocrinology & Metabolism

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies

Georgios Boutzios, Eleni Koukoulioti, Andreas V. Goules, Ioannis Kalliakmanis, Ilias Giovannopoulos, Panayiotis Vlachoyiannopoulos, Haralampos M. Moutsopoulos, Athanasios G. Tzioufas

Summary: This study reveals an association of APCA with organ-specific autoimmunity in HT patients for the first time. APCA and patient age were independently associated with the presence of organ-specific autoimmunity. Additionally, this study showed an association between APCA and gastric neoplasms in these patients.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Immunology

COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases

Athanasios-Dimitrios Bakasis, Clio P. Mavragani, Paraskevi V. Voulgari, Nafsika Gerolymatou, Ourania D. Argyropoulou, Panayiotis G. Vlachoyiannopoulos, Fotini N. Skopouli, Athanasios G. Tzioufas, Haralampos M. Moutsopoulos

Summary: This observational study reports the clinical features and outcomes of COVID-19 in patients with systemic autoimmune and autoinflammatory rheumatic diseases (SAARD) who were unvaccinated or received 2 or 3 doses of the SARS-CoV-2 vaccine. The study found that vaccination with 2 or 3 doses significantly reduced hospitalizations and the need for oxygen supplementation in COVID-19 patients with SAARD. Furthermore, the study showed that receiving 3 doses of the vaccine was associated with a significantly lower risk of severe/critical COVID-19.

JOURNAL OF AUTOIMMUNITY (2022)

Add to Collection

Article Immunology

Liver Fibrosis in Primary Sjogren's Syndrome

Theodoros Androutsakos, Theodoros A. Voulgaris, Athanasios-Dimitrios Bakasis, Maria-Loukia Koutsompina, Loukas Chatzis, Ourania D. Argyropoulou, Vasilis Pezoulas, Dimitrios I. Fotiadis, George Papatheodoridis, Athanasios G. Tzioufas, Andreas V. Goules

Summary: This study explored the occurrence of liver fibrosis (LF) in primary Sjogren syndrome (pSS) patients in the context of non-alcoholic fatty liver disease (NAFLD). The results showed that pSS patients had a lower prevalence of liver steatosis and significant liver fibrosis compared to the comparators. Advanced LF was significantly associated with older age, higher LS, greater BMI, and disease status, with age being identified as an independent LF risk factor.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Rheumatology

A past medical history of autoimmune disease predicts a future with fewer relapses in patients with ANCA-associated vasculitis

S. Lionaki, S. Marinaki, S. Fragkioudaki, I Bellos, E. Kalaitzakis, P. Kalogeropoulos, G. Liapis, A. G. Tzioufas, J. N. Boletis

Summary: This study aimed to explore the impact of a past medical history of autoimmune disease on the clinical presentation and outcomes of patients with antineutrophil cytoplasmic autoantibodies associated vasculitis. The results showed that patients with a history of autoimmune disease had significantly fewer relapses after achieving remission.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Add to Collection

Proceedings Paper Engineering, Biomedical

A federated AI strategy for the classification of patients with Mucosa Associated Lymphoma Tissue (MALT) lymphoma across multiple harmonized cohorts

Vasileios C. Pezoulas, Fanis Kalatzis, Themis P. Exarchos, Luke Chatzis, Saviana Gandolfo, Andreas Goules, Salvatore De Vita, Athanasios G. Tzioufas, Dimitrios Fotiadis

Summary: This study developed MALT classification models across 17 databases on pSS using a federated AI strategy, with the FDART algorithm achieving the best performance for MALT development.

2021 43RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY (EMBC) (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.